Biotechnology (industry)

Compare top 5 →
OverviewAI BriefPerformanceCompositionScoresCompaniesNews
Q-Score57
Market Cap$1.3T
Aggregate P/E—
Dividend Yield0.13%
1Y Return+104.5%
Advancing (1M)25.00%
AI summary

Returns

+104.5%over the year
Cap-weightedMedianUp
1M+6.6%-14.0%25%
3M+29.4%-20.0%25%
YTD+85.1%-26.9%33%
1Y+104.5%-28.5%34%

Led by the largest companies: the median company returned -28.5%.

Returns by horizon and breadth

This month's movers

Leaders
  • PRMEPrime Medicine, Inc.+86.4%
  • PEPGPepGen Inc.+76.0%
  • YDESYD Bio Ltd+65.7%
  • LYELLyell Immunopharma, Inc.+65.4%
  • SLNSilence Therapeutics plc+60.5%
Laggards
  • SNDXSyndax Pharmaceuticals, Inc.-47.4%
  • PGENPrecigen, Inc.-45.5%
  • BCAXBicara Therapeutics Inc.-41.8%
  • URGNUroGen Pharma Ltd.-39.9%
  • ACRSAclaris Therapeutics, Inc.-38.3%
Every horizon's leaders and laggards

News sentiment

Open News

Largest companies

The map and every share

Size

Revenue$119.1B
Earnings$-33.3B
Companies571
Concentration (HHI)0.14
Size and financials

Q-Score profile

57/ 100
Every score and metric

Valuation

Aggregate P/E—
Aggregate P/S11.06
Dividend yield0.13%
Earnings yield—
Net margin-27.92%
The valuation map

Revenue exposure

Outside the US26.46%
From Greater China—
Largest customer (avg.)35.96%
Revenue covered59.67%
Size and financials